Company: IONQ
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0001193125-25-137398
Chunk: 2

Company: IonQ, Inc.
Filing Date: 2025-06-09
Form: 8-K
Item: Item 1.01
Chunk 2
---
 the benefit of the parties to the Agreement; may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures, and may have been made for the purposes of allocating contractual risk between the parties to the Agreement instead of establishing these matters as facts; and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors should not rely on the representations, warranties and covenants, or any descriptions thereof, as characterizations of the actual state of facts or condition of the Company, Oxford Ionics or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Agreement, which subsequent information may or may not be fully reflected in public disclosures by the Company.

  Item 3.02      Unregistered Sales of Equity Securities  

The information set forth under Item 1.01 of this Current Report on Form8-Krelated to the shares of Common Stock to be issued as consideration for the Transaction is incorporated herein by reference. The securities will be issued pursuant to one or more exemptions from registration under the Securities Act of 1933, as amended (the “ Securities Act”), including those provided by Section 4(a)(2) of the Securities Act and Regulation D and Regulation S promulgated under the Securities Act.

  Item 7.01      Regulation FD Disclosure.  

On June 9, 2025, the Company issued a press release announcing its entry into the Agreement. A copy of the press release has been furnished as Exhibit 99.1 to this Current Report on Form8-Kand is incorporated herein by reference.

The information provided pursuant to Item 7.01 of this Form 8-K,